Join Us at the 15th APS PharmSci International Conference!

Date: 4-6 September 2024
Location: University of Huddersfield, UK

We are excited to announce our participation in the 15th APS PharmSci International Conference. Visit us to explore our latest innovations and solutions in the pharmaceutical industry.

Hypromellose (HPMC) is crucial for controlling the release of active pharmaceutical ingredients (APIs) in hydrophilic matrix tablets. This study examines the impact of hydroxypropyl content in HPMC on the robustness of these formulations, focusing on the release rate of APIs like Acetaminophen and Propranolol HCl at varying shear rates.

Mohammad Qadir, Lead Application Scientist, will present our Pharma Solutions’ portfolio with a specific focus on our low nitrite solutions and controlled release offerings.

Location: Room OA5.501 – 5th floor
Date: 4 September 2024
Time: 1.35-1.45pm

Discover our comprehensive controlled release portfolio, low nitrite products, and more! For over 75 years, IFF Pharma Solutions has been a leader in the controlled release domain, consistently introducing groundbreaking products that set new standards in drug delivery.

METHOCEL™ — Pioneering Then, Innovating Now
METHOCEL™ cellulose ethers are the top choice for controlled-release matrix formulations, offering a versatile range of products for both solid and liquid dosage forms.

ETHOCEL™ — Proven Time After Time
ETHOCEL™ ethylcellulose polymers are essential for coating multi-particulates, achieving modified release, and superior taste-masking in various pharmaceutical applications.

POLYOX™ — Versatile Across Complex and Unique Applications
POLYOX™ polyethylene oxide products are pivotal in osmotic pump delivery systems and specialty matrices requiring high swelling, mucoadhesion, abuse deterrence, and exceptional mechanical strength.